why is bpc-157 banned bpc 157 by wada peptide prohibited under WADA regulations PEPTIDES: THE 2026 FDA CRACKDOWN

This classification indicates that: BPC-157 CANNOT be prepared by commercial compounding pharmacies There is insufficient evidence to determine whether it could cause harm in humans The peptide is not approved as a drug WHAT REMAINS LEGAL Despite this classification, many BPC-157 products are legally sold as: "Research chemicals" "Dietary supplements" These categories are not subject to the same regulations as drugs

Important context

It has received Orphan Drug and Fast Track designations, indicating regulatory recognition of its potential

The peptide activates the VEGFR2-Akt-eNOS pathway and increases nitric oxide production, both of which stimulate blood vessel growth